Nephrotoxicity From Chemotherapeutic Agents: Clinical Manifestations, Pathobiology, and Prevention/Therapy

被引:261
作者
Perazella, Mark A. [1 ]
Moeckel, Gilbert W. [2 ]
机构
[1] Yale Univ, Dept Med, Sch Med, Nephrol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
关键词
Chemotherapy; cancer; drugs; nephrotoxicity; cisplatin; methotrexate; ifosfamide; pamidronate; MITOMYCIN-C NEPHROTOXICITY; CISPLATIN NEPHROTOXICITY; KIDNEY; CANCER; METHOTREXATE; THERAPY; PATIENT; EXPRESSION; APOPTOSIS; NECROSIS;
D O I
10.1016/j.semnephrol.2010.09.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Nephrotoxicity remains a vexing complication of chemotherapeutic agents. A number of kidney lesions can result from these drugs, including primarily tubular-limited dysfunction, glomerular injury with proteinuria, full-blown acute kidney injury, and long-term chronic kidney injury. In most cases, these kidney lesions develop from innate toxicity of these medications, but underlying host risk factors and the renal handling of these drugs clearly increase the likelihood of nephrotoxicity. This article reviews some of the classic nephrotoxic chemotherapeutic agents and focuses on examples of the clinical and histopathologic kidney lesions they cause as well as measures that may prevent or treat drug-induced nephrotoxicity. © 2010 Elsevier Inc.
引用
收藏
页码:570 / 581
页数:12
相关论文
共 55 条
[1]
Adverse effects of bisphosphonates - A comparative review [J].
Adami, S ;
Zamberlan, N .
DRUG SAFETY, 1996, 14 (03) :158-170
[2]
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity [J].
Aleksa, K ;
Matsell, D ;
Krausz, K ;
Gelboin, H ;
Ito, S ;
Koren, G .
PEDIATRIC NEPHROLOGY, 2005, 20 (07) :872-885
[3]
KIDNEY CORTICAL NECROSIS INDUCED BY MITOMYCIN-C - A MORPHOLOGICAL EXPERIMENTAL-STUDY [J].
BLANCO, C ;
SAINZMAZA, ML ;
GARIJO, F ;
VALBERNAL, F ;
BUELTA, L ;
FERNANDEZ, F .
RENAL FAILURE, 1992, 14 (01) :31-39
[4]
SIGNIFICANCE OF URINARY GAMMA-GLUTAMYL TRANSFERASE IN RENAL TOXICOLOGY OF RAT - BASES OF USE AND SIGNIFICANCE ON ACUTE MERCURIC NEPHRITIS [J].
BRAUN, JP ;
RICO, AG ;
BENARD, P ;
BURGATSACAZE, V ;
EGHBALI, B ;
GODFRAIN, JC .
TOXICOLOGY, 1978, 11 (01) :73-82
[5]
Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice [J].
Celtikci, Basak ;
Leclerc, Daniel ;
Lawrance, Andrea K. ;
Deng, Liyuan ;
Friedman, Hana C. ;
Krupenko, Natalia I. ;
Krupenko, Sergey A. ;
Melnyk, Stepan ;
James, S. Jill ;
Peterson, Alan C. ;
Rozen, Rima .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (07) :577-589
[6]
Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20
[7]
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 [J].
Ciarimboli, G ;
Ludwig, T ;
Lang, DF ;
Pavenstädt, H ;
Koepsell, H ;
Piechota, HJ ;
Haier, J ;
Jaehde, U ;
Zisowsky, J ;
Schlatter, E .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (06) :1477-1484
[8]
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation [J].
Ciarimboli, G ;
Koepsell, H ;
Iordanova, M ;
Gorboulev, V ;
Dürner, B ;
Lang, D ;
Edemir, B ;
Schröter, R ;
Van Le, T ;
Schlatter, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1562-1570
[9]
Interferon α sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia:: case report and review of literature [J].
Colovic, M. ;
Jurisic, V. ;
Jankovic, G. ;
Jovanovic, D. ;
Nikolic, L. J. ;
Dimitrijevic, J. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (08) :879-881
[10]
CORDONNIER D, 1985, NEPHROLOGIE, V6, P19